{"id":728704,"date":"2023-02-03T16:33:51","date_gmt":"2023-02-03T21:33:51","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-reports-granting-of-inducement-award-7\/"},"modified":"2023-02-03T16:33:51","modified_gmt":"2023-02-03T21:33:51","slug":"t2-biosystems-reports-granting-of-inducement-award-7","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-reports-granting-of-inducement-award-7\/","title":{"rendered":"T2 Biosystems Reports Granting of Inducement Award"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">LEXINGTON, Mass., Feb.  03, 2023  (GLOBE NEWSWIRE) &#8212; T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, and antibiotic resistance genes, announced today that it issued inducement awards to fourteen new employees.<\/p>\n<p align=\"justify\">The awards were made on January 30, 2023, under the T2 Biosystems\u2019 Inducement Award Plan (the &#8220;Inducement Plan&#8221;), which was adopted on March 1, 2018 and amended and restated on December 17, 2021 and provides for the granting of equity awards to new employees of T2 Biosystems. The inducement awards consist of thirteen option grant awards to purchase an aggregate of 6,220 shares of T2 Biosystems common stock and one grant of restricted stock units (\u201cRSUs\u201d) covering 40,000 shares of the Company\u2019s common stock granted to the Company Vice President of Operations, Steve Miller. The exercise price of the options was $1.59 which was the per-share closing price of T2 Biosystems common stock on the Nasdaq Capital Market on January 30, 2023. The options vest over a four-year period, with 25% vesting on the first anniversary of the employee\u2019s date of hire and the remainder vesting in equal monthly installments over the three years thereafter. Subject to Mr. Miller\u2019s continued service to the Company, one third of the RSUs shall vest on each of the first two anniversaries of the grant date and the remainder shall vest on the third anniversary of the grant date. The stock options and the RSU\u2019s each have a ten-year term. The award was approved by the independent compensation committee of T2 Biosystems\u2019 board of directors and was granted as an inducement material to the new employee entering into employment with T2 Biosystems in accordance with Nasdaq Marketplace Rule 5635(c)(4).<\/p>\n<p>\n        <strong>About T2 Biosystems:<\/strong>\n      <\/p>\n<p align=\"justify\">T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems\u2019 products include the T2Dx<sup>\u00ae<\/sup> Instrument, the T2Bacteria<sup>\u00ae<\/sup> Panel, the T2Candida<sup>\u00ae<\/sup> Panel, the T2Resistance<sup>\u00ae<\/sup> Panel, and the T2SARS-CoV-2\u2122 Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR<sup>\u00ae<\/sup>) technology. T2 Biosystems has an active pipeline of future products, including the T2Biothreat\u2122 Panel, the T2Cauris\u2122 Panel, and T2Lyme\u2122 Panel, as well as next-generation products for the detection of bacterial and fungal pathogens and associated antimicrobial resistance markers. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=F-8Z_-OOo9lSl9RXOCtkQhV5lMc_etRR_y_lgDzo-2sTkishaA1efRaP_Tv7pfvsktILu1z177EshuT5-5_4Y7A0nMBo7_jAl7ckO54PO2Y=\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.t2biosystems.com<\/u><\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Philip Trip Taylor, Gilmartin Group<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=i2Kjzs3COzlgFhl3cWRLWSjrQ8DECho-jvvktybVFCq4DALT036Q4gx1785d2C0NmOuAeVUSfDCi5BXnZB6BeAqBorPPEwp-V5eMriRt2K0=\" rel=\"nofollow noopener\" target=\"_blank\">philip@gilmartinIR.com<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cQSmCZR3DJ0-e1_7O5Qp8nQaoFF7LubpLvEAoG_p_9rds0Ias4ICHMStl4_o0mS3Droj51OEp_LTlRr0YB2V7fLQoadvKI5a3LsDpSXOtXvyRxPQmDaGMhrqpq8r2XAFcpmOyf0ES-JyjZwUVOP8tltn9V9SDSkF47HtZSwDtaENypc6CElEa5d6FvI-sl39\" rel=\"nofollow noopener\" target=\"_blank\"><br \/><\/a>415-937-5406<\/p>\n<p>\u00a0<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MjYyMyM1MzkxMTc1IzIwMDU4NDQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTFlZjVlNzgtYWJiNi00NmJmLWI2NGMtYTU2NmViN2EzZmU4LTEwMTc0MTc=\/tiny\/T2-Biosystems-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LEXINGTON, Mass., Feb. 03, 2023 (GLOBE NEWSWIRE) &#8212; T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, and antibiotic resistance genes, announced today that it issued inducement awards to fourteen new employees. The awards were made on January 30, 2023, under the T2 Biosystems\u2019 Inducement Award Plan (the &#8220;Inducement Plan&#8221;), which was adopted on March 1, 2018 and amended and restated on December 17, 2021 and provides for the granting of equity awards to new employees of T2 Biosystems. The inducement awards consist of thirteen option grant awards to purchase an aggregate of 6,220 shares of T2 Biosystems common stock and one grant of restricted stock units (\u201cRSUs\u201d) covering 40,000 shares of the Company\u2019s common stock &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-reports-granting-of-inducement-award-7\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;T2 Biosystems Reports Granting of Inducement Award&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-728704","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>T2 Biosystems Reports Granting of Inducement Award - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-reports-granting-of-inducement-award-7\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"T2 Biosystems Reports Granting of Inducement Award - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LEXINGTON, Mass., Feb. 03, 2023 (GLOBE NEWSWIRE) &#8212; T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, and antibiotic resistance genes, announced today that it issued inducement awards to fourteen new employees. The awards were made on January 30, 2023, under the T2 Biosystems\u2019 Inducement Award Plan (the &#8220;Inducement Plan&#8221;), which was adopted on March 1, 2018 and amended and restated on December 17, 2021 and provides for the granting of equity awards to new employees of T2 Biosystems. The inducement awards consist of thirteen option grant awards to purchase an aggregate of 6,220 shares of T2 Biosystems common stock and one grant of restricted stock units (\u201cRSUs\u201d) covering 40,000 shares of the Company\u2019s common stock &hellip; Continue reading &quot;T2 Biosystems Reports Granting of Inducement Award&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-reports-granting-of-inducement-award-7\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-03T21:33:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MjYyMyM1MzkxMTc1IzIwMDU4NDQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-reports-granting-of-inducement-award-7\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-reports-granting-of-inducement-award-7\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"T2 Biosystems Reports Granting of Inducement Award\",\"datePublished\":\"2023-02-03T21:33:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-reports-granting-of-inducement-award-7\\\/\"},\"wordCount\":417,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-reports-granting-of-inducement-award-7\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MjYyMyM1MzkxMTc1IzIwMDU4NDQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-reports-granting-of-inducement-award-7\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-reports-granting-of-inducement-award-7\\\/\",\"name\":\"T2 Biosystems Reports Granting of Inducement Award - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-reports-granting-of-inducement-award-7\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-reports-granting-of-inducement-award-7\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MjYyMyM1MzkxMTc1IzIwMDU4NDQ=\",\"datePublished\":\"2023-02-03T21:33:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-reports-granting-of-inducement-award-7\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-reports-granting-of-inducement-award-7\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-reports-granting-of-inducement-award-7\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MjYyMyM1MzkxMTc1IzIwMDU4NDQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MjYyMyM1MzkxMTc1IzIwMDU4NDQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-reports-granting-of-inducement-award-7\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"T2 Biosystems Reports Granting of Inducement Award\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"T2 Biosystems Reports Granting of Inducement Award - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-reports-granting-of-inducement-award-7\/","og_locale":"en_US","og_type":"article","og_title":"T2 Biosystems Reports Granting of Inducement Award - Market Newsdesk","og_description":"LEXINGTON, Mass., Feb. 03, 2023 (GLOBE NEWSWIRE) &#8212; T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, and antibiotic resistance genes, announced today that it issued inducement awards to fourteen new employees. The awards were made on January 30, 2023, under the T2 Biosystems\u2019 Inducement Award Plan (the &#8220;Inducement Plan&#8221;), which was adopted on March 1, 2018 and amended and restated on December 17, 2021 and provides for the granting of equity awards to new employees of T2 Biosystems. The inducement awards consist of thirteen option grant awards to purchase an aggregate of 6,220 shares of T2 Biosystems common stock and one grant of restricted stock units (\u201cRSUs\u201d) covering 40,000 shares of the Company\u2019s common stock &hellip; Continue reading \"T2 Biosystems Reports Granting of Inducement Award\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-reports-granting-of-inducement-award-7\/","og_site_name":"Market Newsdesk","article_published_time":"2023-02-03T21:33:51+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MjYyMyM1MzkxMTc1IzIwMDU4NDQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-reports-granting-of-inducement-award-7\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-reports-granting-of-inducement-award-7\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"T2 Biosystems Reports Granting of Inducement Award","datePublished":"2023-02-03T21:33:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-reports-granting-of-inducement-award-7\/"},"wordCount":417,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-reports-granting-of-inducement-award-7\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MjYyMyM1MzkxMTc1IzIwMDU4NDQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-reports-granting-of-inducement-award-7\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-reports-granting-of-inducement-award-7\/","name":"T2 Biosystems Reports Granting of Inducement Award - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-reports-granting-of-inducement-award-7\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-reports-granting-of-inducement-award-7\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MjYyMyM1MzkxMTc1IzIwMDU4NDQ=","datePublished":"2023-02-03T21:33:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-reports-granting-of-inducement-award-7\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-reports-granting-of-inducement-award-7\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-reports-granting-of-inducement-award-7\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MjYyMyM1MzkxMTc1IzIwMDU4NDQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MjYyMyM1MzkxMTc1IzIwMDU4NDQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-reports-granting-of-inducement-award-7\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"T2 Biosystems Reports Granting of Inducement Award"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/728704","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=728704"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/728704\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=728704"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=728704"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=728704"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}